Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Change in Accured Expenses (2016 - 2026)

Standard Biotools has reported Change in Accured Expenses over the past 16 years, most recently at $10.2 million for Q4 2025.

  • Quarterly Change in Accured Expenses rose 233.44% to $10.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.4 million through Dec 2025, up 347.54% year-over-year, with the annual reading at $10.4 million for FY2025, 347.54% up from the prior year.
  • Change in Accured Expenses was $10.2 million for Q4 2025 at Standard Biotools, up from $27000.0 in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $10.2 million in Q4 2025 and troughed at -$8.0 million in Q3 2021.
  • The 5-year median for Change in Accured Expenses is $11000.0 (2024), against an average of -$101526.3.
  • The largest YoY upside for Change in Accured Expenses was 809.71% in 2024 against a maximum downside of 2991.56% in 2024.
  • A 5-year view of Change in Accured Expenses shows it stood at -$8.0 million in 2021, then skyrocketed by 223.41% to $9.9 million in 2022, then plummeted by 37.99% to $6.1 million in 2023, then tumbled by 224.39% to -$7.6 million in 2024, then skyrocketed by 233.44% to $10.2 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Change in Accured Expenses are $10.2 million (Q4 2025), $27000.0 (Q3 2025), and $40000.0 (Q2 2025).